25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CMND (Clearmind Medicine Inc. Common Shares) Stock Analysis
Buy, Hold or Sell?

Let's analyze Clearmind Medicine Inc. Common Shares together

I guess you are interested in Clearmind Medicine Inc. Common Shares. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Clearmind Medicine Inc. Common Shares’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Clearmind Medicine Inc. Common Shares’s Price Targets

I'm going to help you getting a better view of Clearmind Medicine Inc. Common Shares. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Clearmind Medicine Inc. Common Shares

I send you an email if I find something interesting about Clearmind Medicine Inc. Common Shares.

1. Quick Overview

1.1. Quick analysis of Clearmind Medicine Inc. Common Shares (30 sec.)










1.2. What can you expect buying and holding a share of Clearmind Medicine Inc. Common Shares? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.39
Expected worth in 1 year
$0.09
How sure are you?
23.5%

+ What do you gain per year?

Total Gains per Share
$-0.30
Return On Investment
-29.1%

For what price can you sell your share?

Current Price per Share
$1.03
Expected price per share
$0.9205 - $1.2976
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Clearmind Medicine Inc. Common Shares (5 min.)




Live pricePrice per Share (EOD)
$1.03
Intrinsic Value Per Share
$0.20 - $0.44
Total Value Per Share
$0.59 - $0.83

2.2. Growth of Clearmind Medicine Inc. Common Shares (5 min.)




Is Clearmind Medicine Inc. Common Shares growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$1.7m$703.2k28.4%

How much money is Clearmind Medicine Inc. Common Shares making?

Current yearPrevious yearGrowGrow %
Making money-$872k-$1.8m$969.3k111.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Clearmind Medicine Inc. Common Shares (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Clearmind Medicine Inc. Common Shares?

Welcome investor! Clearmind Medicine Inc. Common Shares's management wants to use your money to grow the business. In return you get a share of Clearmind Medicine Inc. Common Shares.

First you should know what it really means to hold a share of Clearmind Medicine Inc. Common Shares. And how you can make/lose money.

Speculation

The Price per Share of Clearmind Medicine Inc. Common Shares is $1.03. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clearmind Medicine Inc. Common Shares.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clearmind Medicine Inc. Common Shares, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.39. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clearmind Medicine Inc. Common Shares.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.15-14.3%-0.17-16.5%-0.28-26.9%-0.19-18.7%-0.11-10.6%
Usd Book Value Change Per Share-0.03-3.4%-0.07-7.3%0.1615.6%0.021.9%0.011.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-3.4%-0.07-7.3%0.1615.6%0.021.9%0.011.1%
Usd Price Per Share1.38-1.40-0.64-2.52-1.41-
Price to Earnings Ratio-2.35--2.26--0.96--1.92--1.07-
Price-to-Total Gains Ratio-39.67--24.92-1.50--22.38--22.38-
Price to Book Ratio3.53-3.04-2.17-12.62-7.05-
Price-to-Total Gains Ratio-39.67--24.92-1.50--22.38--22.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.03
Number of shares970
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.02
Usd Total Gains Per Share-0.070.02
Gains per Quarter (970 shares)-72.6819.20
Gains per Year (970 shares)-290.7476.79
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-291-30107767
20-581-5920154144
30-872-8830230221
40-1163-11740307298
50-1454-14650384375
60-1744-17560461452
70-2035-20470538529
80-2326-23380614606
90-2617-26290691683
100-2907-29200768760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.010.01.00.0%0.018.01.00.0%0.033.01.00.0%0.033.01.00.0%
Book Value Change Per Share0.04.00.00.0%3.07.01.027.3%6.012.01.031.6%8.023.03.023.5%8.023.03.023.5%
Dividend per Share0.00.04.00.0%0.00.011.00.0%0.00.019.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share0.04.00.00.0%3.07.01.027.3%6.012.01.031.6%8.023.03.023.5%8.023.03.023.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Clearmind Medicine Inc. Common Shares compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.035-0.075+115%0.160-122%0.020-276%0.011-402%
Book Value Per Share--0.3910.482-19%0.345+13%0.326+20%0.188+108%
Current Ratio--1.7221.804-5%1.623+6%10.966-84%7.586-77%
Debt To Asset Ratio--0.5670.547+4%0.653-13%0.350+62%4.494-87%
Debt To Equity Ratio--1.3081.225+7%2.976-56%1.139+15%0.703+86%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--8622903.0339319314.999-7%4673308.915+85%23986557.177-64%23986557.177-64%
Eps---0.147-0.170+16%-0.277+89%-0.192+31%-0.109-26%
Ev To Ebitda Ratio---3.029-2.560-15%-1.017-66%infnan%infnan%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.173-0.160-8%-0.096-44%-0.120-31%-0.077-56%
Free Cash Flow To Equity Per Share---0.118-0.113-4%0.257-146%0.023-604%0.014-942%
Gross Profit Margin--1.0001.0000%1.0000%0.947+6%0.971+3%
Intrinsic Value_10Y_max--0.438--------
Intrinsic Value_10Y_min--0.201--------
Intrinsic Value_1Y_max---0.375--------
Intrinsic Value_1Y_min---0.369--------
Intrinsic Value_3Y_max---0.808--------
Intrinsic Value_3Y_min---0.778--------
Intrinsic Value_5Y_max---0.856--------
Intrinsic Value_5Y_min---0.822--------
Market Cap5288833.700-34%7086010.2007211427.446-2%3269449.163+117%12922536.817-45%7221417.633-2%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio2.634-34%3.5303.037+16%2.171+63%12.620-72%7.052-50%
Pe Ratio-1.754+25%-2.350-2.262-4%-0.961-59%-1.918-18%-1.072-54%
Price Per Share1.030-34%1.3801.404-2%0.637+117%2.517-45%1.406-2%
Price To Free Cash Flow Ratio-1.485+25%-1.990-2.208+11%-5.521+177%-3.088+55%-1.726-13%
Price To Total Gains Ratio-29.612+25%-39.675-24.921-37%1.504-2738%-22.377-44%-22.377-44%
Quick Ratio--1.6811.790-6%1.604+5%11.189-85%7.689-78%
Return On Assets---0.163-0.161-1%-0.462+184%-0.478+193%-1.252+669%
Return On Equity---0.376-0.365-3%-2.292+510%-1.182+215%-0.724+93%
Total Gains Per Share---0.035-0.075+115%0.160-122%0.020-276%0.011-402%
Usd Book Value--2007561.0662476303.116-19%1773042.658+13%1675993.111+20%965561.530+108%
Usd Book Value Change Per Share---0.035-0.075+115%0.160-122%0.020-276%0.011-402%
Usd Book Value Per Share--0.3910.482-19%0.345+13%0.326+20%0.188+108%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--8622903.0339319314.999-7%4673308.915+85%23986557.177-64%23986557.177-64%
Usd Eps---0.147-0.170+16%-0.277+89%-0.192+31%-0.109-26%
Usd Free Cash Flow---890233.523-821410.645-8%-495419.859-44%-584732.841-34%-335951.153-62%
Usd Free Cash Flow Per Share---0.173-0.160-8%-0.096-44%-0.120-31%-0.077-56%
Usd Free Cash Flow To Equity Per Share---0.118-0.113-4%0.257-146%0.023-604%0.014-942%
Usd Market Cap5288833.700-34%7086010.2007211427.446-2%3269449.163+117%12922536.817-45%7221417.633-2%
Usd Price Per Share1.030-34%1.3801.404-2%0.637+117%2.517-45%1.406-2%
Usd Profit---753885.374-872076.012+16%-1841451.478+144%-1104880.804+47%-626060.183-17%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.035-0.075+115%0.160-122%0.020-276%0.011-402%
 EOD+3 -5MRQTTM+9 -23YOY+18 -145Y+12 -2010Y+11 -21

3.3 Fundamental Score

Let's check the fundamental score of Clearmind Medicine Inc. Common Shares based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.754
Price to Book Ratio (EOD)Between0-12.634
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.681
Current Ratio (MRQ)Greater than11.722
Debt to Asset Ratio (MRQ)Less than10.567
Debt to Equity Ratio (MRQ)Less than11.308
Return on Equity (MRQ)Greater than0.15-0.376
Return on Assets (MRQ)Greater than0.05-0.163
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Clearmind Medicine Inc. Common Shares based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.592
Ma 20Greater thanMa 501.098
Ma 50Greater thanMa 1001.228
Ma 100Greater thanMa 2001.317
OpenGreater thanClose1.020
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is based in Vancouver, Canada.

Fundamental data was last updated by Penke on 2025-04-04 12:16:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Clearmind Medicine Inc. Common Shares earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Clearmind Medicine Inc. Common Shares to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--109.6%+109.6%
TTM--185.9%+185.9%
YOY--206.2%+206.2%
5Y--408.8%+408.8%
10Y--522.9%+522.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Clearmind Medicine Inc. Common Shares is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Clearmind Medicine Inc. Common Shares to theΒ Biotechnology industry mean.
  • -16.3% Return on Assets means thatΒ Clearmind Medicine Inc. Common Shares generatedΒ $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is -16.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-16.1%-0.2%
TTM-16.1%YOY-46.2%+30.1%
TTM-16.1%5Y-47.8%+31.7%
5Y-47.8%10Y-125.2%+77.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-14.2%-2.1%
TTM-16.1%-14.6%-1.5%
YOY-46.2%-14.4%-31.8%
5Y-47.8%-15.5%-32.3%
10Y-125.2%-18.0%-107.2%
4.3.1.3. Return on Equity

Shows how efficient Clearmind Medicine Inc. Common Shares is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Clearmind Medicine Inc. Common Shares to theΒ Biotechnology industry mean.
  • -37.6% Return on Equity means Clearmind Medicine Inc. Common Shares generated $-0.38Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is -37.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -36.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.6%TTM-36.5%-1.1%
TTM-36.5%YOY-229.2%+192.8%
TTM-36.5%5Y-118.2%+81.7%
5Y-118.2%10Y-72.4%-45.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.6%-17.6%-20.0%
TTM-36.5%-18.2%-18.3%
YOY-229.2%-19.1%-210.1%
5Y-118.2%-24.3%-93.9%
10Y-72.4%-26.0%-46.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Clearmind Medicine Inc. Common Shares.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Clearmind Medicine Inc. Common Shares is operatingΒ .

  • Measures how much profit Clearmind Medicine Inc. Common Shares makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Clearmind Medicine Inc. Common Shares to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.7%+223.7%
TTM--281.1%+281.1%
YOY--226.6%+226.6%
5Y--393.8%+393.8%
10Y--503.6%+503.6%
4.3.2.2. Operating Ratio

Measures how efficient Clearmind Medicine Inc. Common Shares is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.324-2.324
TTM-3.192-3.192
YOY-3.069-3.069
5Y-5.133-5.133
10Y-7.010-7.010
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Clearmind Medicine Inc. Common Shares.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Clearmind Medicine Inc. Common Shares is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.72Β means the company has $1.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is 1.722. The company is able to pay all its short-term debts. +1
  • The TTM is 1.804. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.722TTM1.804-0.082
TTM1.804YOY1.623+0.181
TTM1.8045Y10.966-9.162
5Y10.96610Y7.586+3.380
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7223.776-2.054
TTM1.8043.930-2.126
YOY1.6234.470-2.847
5Y10.9665.748+5.218
10Y7.5866.099+1.487
4.4.3.2. Quick Ratio

Measures if Clearmind Medicine Inc. Common Shares is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Clearmind Medicine Inc. Common Shares to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.68Β means the company can pay off $1.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is 1.681. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.790. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.681TTM1.790-0.109
TTM1.790YOY1.604+0.186
TTM1.7905Y11.189-9.399
5Y11.18910Y7.689+3.500
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6813.102-1.421
TTM1.7903.367-1.577
YOY1.6044.358-2.754
5Y11.1895.731+5.458
10Y7.6896.427+1.262
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Clearmind Medicine Inc. Common Shares.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Clearmind Medicine Inc. Common SharesΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Clearmind Medicine Inc. Common Shares to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.57Β means that Clearmind Medicine Inc. Common Shares assets areΒ financed with 56.7% credit (debt) and the remaining percentage (100% - 56.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is 0.567. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.547. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.547+0.020
TTM0.547YOY0.653-0.106
TTM0.5475Y0.350+0.197
5Y0.35010Y4.494-4.144
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5670.340+0.227
TTM0.5470.340+0.207
YOY0.6530.318+0.335
5Y0.3500.364-0.014
10Y4.4940.393+4.101
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Clearmind Medicine Inc. Common Shares is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Clearmind Medicine Inc. Common Shares to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 130.8% means that company has $1.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The MRQ is 1.308. The company is able to pay all its debts with equity. +1
  • The TTM is 1.225. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.308TTM1.225+0.083
TTM1.225YOY2.976-1.751
TTM1.2255Y1.139+0.086
5Y1.13910Y0.703+0.436
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3080.399+0.909
TTM1.2250.407+0.818
YOY2.9760.389+2.587
5Y1.1390.428+0.711
10Y0.7030.460+0.243
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Clearmind Medicine Inc. Common Shares generates.

  • Above 15 is considered overpriced butΒ always compareΒ Clearmind Medicine Inc. Common Shares to theΒ Biotechnology industry mean.
  • A PE ratio of -2.35 means the investor is paying $-2.35Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The EOD is -1.754. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.350. Based on the earnings, the company is expensive. -2
  • The TTM is -2.262. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.754MRQ-2.350+0.596
MRQ-2.350TTM-2.262-0.087
TTM-2.262YOY-0.961-1.301
TTM-2.2625Y-1.918-0.344
5Y-1.91810Y-1.072-0.846
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.754-1.736-0.018
MRQ-2.350-2.674+0.324
TTM-2.262-3.229+0.967
YOY-0.961-3.337+2.376
5Y-1.918-6.386+4.468
10Y-1.072-7.280+6.208
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The EOD is -1.485. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.990. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.208. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.485MRQ-1.990+0.505
MRQ-1.990TTM-2.208+0.218
TTM-2.208YOY-5.521+3.313
TTM-2.2085Y-3.088+0.880
5Y-3.08810Y-1.726-1.362
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.485-2.257+0.772
MRQ-1.990-3.660+1.670
TTM-2.208-4.254+2.046
YOY-5.521-4.479-1.042
5Y-3.088-8.682+5.594
10Y-1.726-9.845+8.119
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Clearmind Medicine Inc. Common Shares is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 3.53 means the investor is paying $3.53Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Clearmind Medicine Inc. Common Shares:

  • The EOD is 2.634. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.530. Based on the equity, the company is fair priced.
  • The TTM is 3.037. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.634MRQ3.530-0.895
MRQ3.530TTM3.037+0.492
TTM3.037YOY2.171+0.867
TTM3.0375Y12.620-9.583
5Y12.62010Y7.052+5.568
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6341.641+0.993
MRQ3.5302.266+1.264
TTM3.0372.443+0.594
YOY2.1712.468-0.297
5Y12.6203.790+8.830
10Y7.0524.287+2.765
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Clearmind Medicine Inc. Common Shares.

4.8.1. Institutions holding Clearmind Medicine Inc. Common Shares

Institutions are holding 11.934% of the shares of Clearmind Medicine Inc. Common Shares.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Gotham Asset Management, LLC7.30490.048534286438561.1374
2024-12-31AdvisorShares Investments, LLC3.57630.0447167856-2785-1.6321
2024-12-31Virtu Financial LLC0.84110.002939479394790
2024-12-31Citadel Advisors Llc0.81303815820429115.2293
2024-12-31Cornerstone Wealth Group, LLC0.42610.00232000000
2024-12-31Morgan Stanley - Brokerage Accounts0.05460256425640
2024-12-31Tower Research Capital LLC0.019909359350
2024-12-31Royal Bank of Canada0.0121056900
2024-09-30Geode Capital Management, LLC000-16586-100
2024-12-31HRT FINANCIAL LLC000-12756-100
2024-12-31UBS Group AG000-141337-100
Total 13.0480.0984612425-106201-17.3%

4.9.2. Funds holding Clearmind Medicine Inc. Common Shares

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-02-28AdvisorShares Psychedelics ETF4.70712.859722093300
Total 4.70712.859722093300.0%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-01-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets6,585
Total Liabilities3,731
Total Stockholder Equity2,854
 As reported
Total Liabilities 3,731
Total Stockholder Equity+ 2,854
Total Assets = 6,585

Assets

Total Assets6,585
Total Current Assets6,415
Long-term Assets170
Total Current Assets
Cash And Cash Equivalents 5,781
Short-term Investments 135
Net Receivables 210
Other Current Assets 289
Total Current Assets  (as reported)6,415
Total Current Assets  (calculated)6,415
+/-0
Long-term Assets
Property Plant Equipment 44
Long-term Assets Other 20
Long-term Assets  (as reported)170
Long-term Assets  (calculated)64
+/- 106

Liabilities & Shareholders' Equity

Total Current Liabilities3,724
Long-term Liabilities7
Total Stockholder Equity2,854
Total Current Liabilities
Short-term Debt 39
Accounts payable 654
Other Current Liabilities 3,031
Total Current Liabilities  (as reported)3,724
Total Current Liabilities  (calculated)3,724
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt7
Long-term Liabilities  (as reported)7
Long-term Liabilities  (calculated)7
+/-0
Total Stockholder Equity
Common Stock24,759
Retained Earnings -25,094
Accumulated Other Comprehensive Income -21
Other Stockholders Equity 3,210
Total Stockholder Equity (as reported)2,854
Total Stockholder Equity (calculated)2,854
+/-0
Other
Capital Stock24,759
Cash and Short Term Investments 5,916
Common Stock Shares Outstanding 4,489
Liabilities and Stockholders Equity 6,585
Net Debt -5,735
Net Invested Capital 2,854
Net Working Capital 2,691
Property Plant and Equipment Gross 44
Short Long Term Debt Total 46



5.2. Balance Sheets Structured

Currency in CAD. All numbers in thousands.

 Trend2025-01-312024-10-312024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-01-312016-10-312016-07-312016-04-30
> Total Assets 
4
2
4
2
0
0
296
296
250
247
219
209
189
178
178
671
589
513
433
1,965
7,062
5,159
3,260
2,077
1,147
0
1,128
5,996
4,324
5,953
10,098
8,846
8,173
7,255
6,585
6,5857,2558,1738,84610,0985,9534,3245,9961,12801,1472,0773,2605,1597,0621,965433513589671178178189209219247250296296002424
   > Total Current Assets 
4
2
4
2
0
0
270
270
154
82
54
45
15
4
3
487
405
333
243
1,775
6,673
4,920
3,033
1,856
887
0
593
5,842
4,209
5,795
9,843
8,691
7,995
7,088
6,415
6,4157,0887,9958,6919,8435,7954,2095,84259308871,8563,0334,9206,6731,7752433334054873415455482154270270002424
       Cash And Cash Equivalents 
4
2
4
2
0
0
255
255
151
74
47
42
13
1
2
482
401
330
237
1,394
6,603
4,599
2,812
1,014
511
0
176
5,246
3,943
5,428
9,286
8,306
7,680
6,574
5,781
5,7816,5747,6808,3069,2865,4283,9435,24617605111,0142,8124,5996,6031,3942373304014822113424774151255255002424
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
554
554
306
0
264
135
63
86
87
0
0
289
135
1352890087866313526403065545540000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
3
8
8
3
2
3
2
5
3
3
6
381
70
161
123
247
48
0
134
198
175
240
154
175
191
181
210
210181191175154240175198134048247123161703816335232388300000000
       Other Current Assets 
0
0
0
0
0
0
15
15
0
0
0
0
0
0
0
0
0
0
0
0
160
160
97
41
21
0
19
357
70
56
317
211
124
44
289
2894412421131756703571902141971601600000000000001515000000
   > Long-term Assets 
0
0
0
0
0
0
25
25
96
165
165
165
175
175
175
185
185
180
190
190
389
239
227
221
260
0
535
154
115
159
254
155
179
167
170
1701671791552541591151545350260221227239389190190180185185175175175165165165962525000000
       Property Plant Equipment 
0
0
0
0
0
0
25
25
96
165
165
165
175
175
175
185
185
180
190
190
190
21
19
16
59
0
66
14
1
2
96
1
60
52
44
445260196211466059161921190190190180185185175175175165165165962525000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
198
188
185
181
178
178
0
120
0
157
157
111
108
0
0108111157157012001781781811851881982002000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
20
20
20
20
0
0
15
8
0
0
0
0
0
0
00000081500202020202000000000000000000000
> Total Liabilities 
40
43
50
56
0
0
65
65
64
8
2
29
31
45
69
26
15
13
32
28
440
357
192
247
783
0
2,638
2,654
3,610
4,970
5,056
4,200
4,700
4,148
3,731
3,7314,1484,7004,2005,0564,9703,6102,6542,6380783247192357440283213152669453129286465650056504340
   > Total Current Liabilities 
40
43
50
56
0
0
65
65
64
8
2
29
31
45
69
26
15
13
32
28
440
357
192
247
783
0
2,638
2,654
3,610
4,970
5,026
4,200
4,675
4,131
3,724
3,7244,1314,6754,2005,0264,9703,6102,6542,6380783247192357440283213152669453129286465650056504340
       Short-term Debt 
27
28
31
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49
49
0
52
5
0
64
64
0
35
37
39
39373506464055204949000000000000000000032312827
       Short Long Term Debt 
27
28
31
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000032312827
       Accounts payable 
13
15
19
24
0
0
0
4
4
8
2
2
2
13
51
21
7
5
29
21
339
349
146
214
597
0
1,907
805
448
617
609
421
277
526
654
6545262774216096174488051,907059721414634933921295721511322284400024191513
       Other Current Liabilities 
0
0
0
0
0
0
65
65
60
0
27
27
28
32
18
5
8
8
4
8
101
8
46
33
138
0
678
1,795
3,162
4,353
4,353
3,779
4,363
3,569
3,031
3,0313,5694,3633,7794,3534,3533,1621,7956780138334681018488518322827270606565000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
4
4
8
2
2
2
13
51
21
7
5
29
21
339
349
146
214
645
0
1,959
0
0
31
31
0
26
16
7
7162603131001,95906452141463493392129572151132228440000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
270
0
0
0
0
0
0
0
0
0
0
0000000000270000000000000000000000000
> Total Stockholder Equity
-36
-41
-46
-54
0
0
231
231
186
239
217
180
159
134
109
645
574
499
401
1,937
6,622
4,802
3,068
1,829
363
0
-1,510
3,342
714
983
5,041
4,646
3,473
3,108
2,854
2,8543,1083,4734,6465,0419837143,342-1,51003631,8293,0684,8026,6221,93740149957464510913415918021723918623123100-54-46-41-36
   Common Stock
1
1
1
1
0
0
272
272
246
293
293
293
293
293
293
891
892
892
892
2,274
7,905
7,906
7,934
9,326
9,326
0
9,154
14,758
12,444
17,131
22,523
22,758
23,801
24,168
24,759
24,75924,16823,80122,75822,52317,13112,44414,7589,15409,3269,3267,9347,9067,9052,274892892892891293293293293293293246272272001111
   Retained Earnings Total Equity00000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-15
-15
0
2,208
2,208
2,766
0
644
440
-15
-21
-21
-21
-21
2,962
-21
-212,962-21-21-21-21-1544064402,7662,2082,2080-15-150000000000000000000
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
147
147
147
147
147
147
147
147
147
147
147
489
642
1,335
1,663
2,766
2,543
0
2,543
2,267
1,915
2,642
2,675
2,954
2,831
0
3,210
3,21002,8312,9542,6752,6421,9152,2672,54302,5432,7661,6631,33564248914714714714714714714714714714714700000000



5.3. Balance Sheets

Currency in CAD. All numbers in thousands.




5.4. Cash Flows

Currency in CAD. All numbers in thousands.




5.5. Income Statements

Currency in CAD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-10-31. Currency in CAD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-27
Gross Profit-27-27
 
Operating Income (+$)
Gross Profit-27
Operating Expense-5,718
Operating Income-6,300-5,745
 
Operating Expense (+$)
Research Development1,377
Selling General Administrative3,262
Selling And Marketing Expenses-
Operating Expense5,7184,640
 
Net Interest Income (+$)
Interest Income271
Interest Expense-36
Other Finance Cost-0
Net Interest Income235
 
Pretax Income (+$)
Operating Income-6,300
Net Interest Income235
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-4,877-7,325
EBIT - interestExpense = -5,942
-4,877
-5,219
Interest Expense36
Earnings Before Interest and Taxes (EBIT)-5,905-4,841
Earnings Before Interest and Taxes (EBITDA)-5,854
 
After tax Income (+$)
Income Before Tax-4,877
Tax Provision-378
Net Income From Continuing Ops-5,255-5,255
Net Income-5,255
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses2,573
Total Other Income/Expenses Net1,025-235
 

Technical Analysis of Clearmind Medicine Inc. Common Shares
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clearmind Medicine Inc. Common Shares. The general trend of Clearmind Medicine Inc. Common Shares is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clearmind Medicine Inc. Common Shares's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Clearmind Medicine Inc. Common Shares Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clearmind Medicine Inc. Common Shares.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.05 < 1.06 < 1.2976.

The bearish price targets are: 0.9512 > 0.9205.

Know someone who trades $CMND? Share this with them.πŸ‘‡

Clearmind Medicine Inc. Common Shares Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clearmind Medicine Inc. Common Shares. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clearmind Medicine Inc. Common Shares Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clearmind Medicine Inc. Common Shares. The current macd is -0.05535195.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clearmind Medicine Inc. Common Shares price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Clearmind Medicine Inc. Common Shares. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Clearmind Medicine Inc. Common Shares price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Clearmind Medicine Inc. Common Shares Daily Moving Average Convergence/Divergence (MACD) ChartClearmind Medicine Inc. Common Shares Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clearmind Medicine Inc. Common Shares. The current adx is 11.37.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Clearmind Medicine Inc. Common Shares shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Clearmind Medicine Inc. Common Shares Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clearmind Medicine Inc. Common Shares. The current sar is 1.18735866.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Clearmind Medicine Inc. Common Shares Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clearmind Medicine Inc. Common Shares. The current rsi is 34.59. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Clearmind Medicine Inc. Common Shares Daily Relative Strength Index (RSI) ChartClearmind Medicine Inc. Common Shares Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clearmind Medicine Inc. Common Shares. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Clearmind Medicine Inc. Common Shares price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Clearmind Medicine Inc. Common Shares Daily Stochastic Oscillator ChartClearmind Medicine Inc. Common Shares Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clearmind Medicine Inc. Common Shares. The current cci is -117.92210946.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Clearmind Medicine Inc. Common Shares Daily Commodity Channel Index (CCI) ChartClearmind Medicine Inc. Common Shares Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clearmind Medicine Inc. Common Shares. The current cmo is -37.76424345.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Clearmind Medicine Inc. Common Shares Daily Chande Momentum Oscillator (CMO) ChartClearmind Medicine Inc. Common Shares Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clearmind Medicine Inc. Common Shares. The current willr is -89.7083473.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Clearmind Medicine Inc. Common Shares Daily Williams %R ChartClearmind Medicine Inc. Common Shares Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Clearmind Medicine Inc. Common Shares.

Clearmind Medicine Inc. Common Shares Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clearmind Medicine Inc. Common Shares. The current atr is 0.06412838.

Clearmind Medicine Inc. Common Shares Daily Average True Range (ATR) ChartClearmind Medicine Inc. Common Shares Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clearmind Medicine Inc. Common Shares. The current obv is 306,221,962.

Clearmind Medicine Inc. Common Shares Daily On-Balance Volume (OBV) ChartClearmind Medicine Inc. Common Shares Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clearmind Medicine Inc. Common Shares. The current mfi is 67.55.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Clearmind Medicine Inc. Common Shares Daily Money Flow Index (MFI) ChartClearmind Medicine Inc. Common Shares Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clearmind Medicine Inc. Common Shares.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Clearmind Medicine Inc. Common Shares Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clearmind Medicine Inc. Common Shares based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.592
Ma 20Greater thanMa 501.098
Ma 50Greater thanMa 1001.228
Ma 100Greater thanMa 2001.317
OpenGreater thanClose1.020
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Clearmind Medicine Inc. Common Shares with someone you think should read this too:
  • Are you bullish or bearish on Clearmind Medicine Inc. Common Shares? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clearmind Medicine Inc. Common Shares? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clearmind Medicine Inc. Common Shares

I send you an email if I find something interesting about Clearmind Medicine Inc. Common Shares.


Comments

How you think about this?

Leave a comment

Stay informed about Clearmind Medicine Inc. Common Shares.

Receive notifications about Clearmind Medicine Inc. Common Shares in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.